Imperva (IMPV) Tops Q4 EPS by 5c, Q1 & FY16 Guidance Falls Short

Imperva (NYSE: IMPV) reported Q4 EPS of $0.20, $0.05 better than the analyst estimate of $0.15. Revenue for the quarter came in at $72.7 million versus the consensus estimate of $68.16 million.

GUIDANCE:

Imperva sees Q1 2016 EPS of ($0.26)-($0.32), versus the consensus of ($0.12). Imperva sees Q1 2016 revenue of $58-60 million, versus the consensus of $59.83 million.

Imperva sees FY2016 EPS of $0.17-$0.23, versus the consensus of $0.31. Imperva sees FY2016 revenue of $302-307 million, versus the consensus of $290.23 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.

You May Also Be Interested In

• RH (RH) Tops Q1 EPS by 12c
• Honeywell Technologies sets three-year targets ahead of aerospace spin-off
• Stitch Fix (SFIX) Tops Q3 EPS by 4c, Offers Guidance